BIOTA Biosciences LLC is recalling various 10mL sterile injectable vials containing Cannabidiol (CBD) and Curcumin. These products are being recalled because they lack assurance of sterility and were marketed without required FDA approval. The recall includes five different product formulations, including combined CBD and Curcumin vials, with expiration dates in July and October 2021. These products were distributed nationwide in the United States and in New Zealand.
Products that are intended to be sterile but lack proper sterility assurance pose a significant risk of serious infection to patients when administered. Additionally, these products contain CBD and Curcumin as active drug ingredients that have not been evaluated or approved by the FDA for safety or effectiveness.
Healthcare guidance and product refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.